1. Evaluation of oxidant-antioxidant balance and DNA damage in blood of patients with cancer of the head and neck under the influence of copper(II) complex: Preliminary studies
- Author
-
Katarzyna Malinowska, Dariusz Kaczmarczyk, Alina Morawiec-Sztandera, Małgorzata Majczyk, Anna Merecz-Sadowska, Hanna Zielinska-Blizniewska, and Radosław Zajdel
- Subjects
Microbiology (medical) ,GPX ,business.industry ,Oxidant antioxidant ,Cancer ,chemistry.chemical_element ,CAT ,Pharmacology ,medicine.disease ,Copper ,03 medical and health sciences ,0302 clinical medicine ,Infectious Diseases ,chemistry ,030220 oncology & carcinogenesis ,medicine ,Medicine ,head and neck cancer ,SOD ,030223 otorhinolaryngology ,business ,Balance (ability) ,copper complex - Abstract
Introduction: The primary aim of this research was to evaluate the oxidative stress markers and the level of oxidative DNA damage in the pathogenesis of head and neck cancer. Materials/Methods: Sixty-two subjects matched for age and gender, including 31 patients with head and neck cancer and 31 control patients without cancer symptoms, were enrolled in our study. In our work, the activity of antioxidant enzymes: catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPX), as well as a total antioxidant status (TAS), were estimated. Additionally, an alkaline comet assay was used to measure the level of DNA damage in the group of patients with head and neck cancer and the group of healthy control patients. These tests were performed on a blood sample with and without prior incubation of dinitratebis (1-phenyl-5-(2-hydroxyphenyl)-3-methyl-N1pyrazol-κN2)cooper(II). Results: Significant increases of SOD, GPX CAT, TAS (P
- Published
- 2020